Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Freyer

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Critical Reviews in Oncology/Hematology|November 11, 2003
Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderlyBrigitte Tranchand, Silvy Laporte, Olivier Glehen, et al.
Clinical Pharmacokinetics|November 27, 2012
Pharmacodynamic models for discrete dataInes Paule, Pascal Girard, Gilles Freyer, et al.
La Revue Du Praticien|July 26, 2003
[Secondary lung cancers]Bénédicte Etienne-Mastroïanni, Gilles Freyer, Jean-François Cordier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Biology of cancer and aging: a complex association with cellular senescenceClaire Falandry, Marc Bonnefoy, Gilles Freyer, et al.
The Oncologist|June 28, 2011
Current targeted therapies in breast cancer: clinical applications in the elderly womanJean-Philippe Spano, Claire Falandry, Pascal Chaibi, et al.
Drugs & Aging|April 20, 2023
Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective DatabaseGabriel Antherieu, Maël Heiblig, Gilles Freyer, et al.
Clinical Pharmacokinetics|March 7, 2016
Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer TherapyChristophe Meille, Dominique Barbolosi, Joseph Ciccolini, et al.
Presse Medicale (Paris, France : 1983)|July 1, 2005
[The handling of anti-cancer drugs in elderly patients]Sylvain Gaujard, Gilles Albrand, Marc Bonnefoy, et al.
Therapie|June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]Emilie Hénin, Benoit You, Brigitte Tranchand, et al.
Cancer|May 17, 2002
Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patientsSarah Taieb, Véronique Trillet-Lenoir, Loïc Rambaud, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Critical Reviews in Oncology/Hematology|November 11, 2003
Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderlyBrigitte Tranchand, Silvy Laporte, Olivier Glehen, et al.
Clinical Pharmacokinetics|November 27, 2012
Pharmacodynamic models for discrete dataInes Paule, Pascal Girard, Gilles Freyer, et al.
La Revue Du Praticien|July 26, 2003
[Secondary lung cancers]Bénédicte Etienne-Mastroïanni, Gilles Freyer, Jean-François Cordier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Biology of cancer and aging: a complex association with cellular senescenceClaire Falandry, Marc Bonnefoy, Gilles Freyer, et al.
The Oncologist|June 28, 2011
Current targeted therapies in breast cancer: clinical applications in the elderly womanJean-Philippe Spano, Claire Falandry, Pascal Chaibi, et al.
Drugs & Aging|April 20, 2023
Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective DatabaseGabriel Antherieu, Maël Heiblig, Gilles Freyer, et al.
Clinical Pharmacokinetics|March 7, 2016
Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer TherapyChristophe Meille, Dominique Barbolosi, Joseph Ciccolini, et al.
Presse Medicale (Paris, France : 1983)|July 1, 2005
[The handling of anti-cancer drugs in elderly patients]Sylvain Gaujard, Gilles Albrand, Marc Bonnefoy, et al.
Therapie|June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]Emilie Hénin, Benoit You, Brigitte Tranchand, et al.
Cancer|May 17, 2002
Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patientsSarah Taieb, Véronique Trillet-Lenoir, Loïc Rambaud, et al.
Pageof 15